Seuss+

Small and mid-sized biotech companies like yours face intense pressure to deliver results, often with limited resources. That’s why we’ve pivoted at Seuss+—to focus on what matters most to you. Fewer delays minimized risks, and smoother clinical trials. We’re here to partner with you every step of the way. Let’s align your vendor relationships to drive success. https://hubs.ly/Q02S76kF0 #Biotech #Pharma #ClinicalTrials #VendorManagement #ClinicalDevelopment

We are redefining vendor relationships, recognizing them as key drivers in clinical success. With our Vendor Relationship Maximization Method (VRMM), sponsors gain structured, end-to-end support—from the first alignment to quality assurance. Learn how Seuss+ is helping sponsors streamline vendor partnerships for more efficient, compliant trials. https://hubs.ly/Q02S9MWX0 #VendorOptimization #ClinicalSuccess #SeussPlus #ClinicalTrials #PharmaPartnerships #BiotechInnovation #VRMM #ClinicalCompliance

At Seuss+, we know that managing a lean team while moving clinical trials forward isn’t easy. You’re juggling tight timelines, vendor coordination, and regulatory pressure. We get it, and we’ve refined our services to help. We’ve evolved to meet your needs with a sharper focus on maximizing vendor partnerships. Whether it’s vendor strategy, risk management, or inspection readiness, we’ll work with you to streamline your processes and reduce delays. https://hubs.ly/Q02S76_x0 #Biotech #Pharma #ClinicalTrials #VendorManagement #ClinicalDevelopment

Welcome to the October Seuss+ Newsletter! As the life sciences industry adapts to new guidance from global authorities like the WHO and FDA, Seuss+ is also evolving to better support the needs of our clients. We’re sharpening our focus on aligning stakeholders at every stage of clinical development—from optimizing vendor relationships to streamlining operational compliance. This month’s updates touch on recent regulatory shifts affecting clinical trial design and the critical role of alignment in biotech-CRO partnerships.   Thank you for reading and being part of this journey with us!

65% of your clinical trial budget is likely going to vendors, making the pre-selection landscape daunting yet essential to navigate well. Before committing, biotech sponsors must make sense of evolving options to find vendors who deliver on both timelines and trial quality. Here’s how to approach this crucial landscape with clarity and strategy. https://hubs.ly/Q02S76kW0 #clinicaltrials #vendorlandscape #biopharma #biotech #sponsorstrategy

At Seuss+, we’ve been listening—and we’ve evolved. Our focus is sharper, and our services are more refined to support the unique challenges you face in clinical development. Whether it’s navigating vendor selection, mitigating trial risks, or preparing for inspections, we’re here to help you build stronger, more effective vendor relationships. With our Vendor Relationship Maximization Method (VRMM), we ensure your vendors become a strategic advantage, not a hurdle. Why did we pivot? Because your success is our mission. Let’s work together to drive life-saving therapies to patients faster—without compromise. https://hubs.ly/Q02S76kp0 #VendorOptimization #Biotech #ClinicalTrials #clinicaldevelopment #PharmaSuccess

A big thank you to Victoria Bangieva, PhD and Lauren Alani for taking the time to be on our latest podcast episode. It was great to hear how The Digital Medicine Society (DiMe) is “Your Bold, Brave Partner In Digital Medicine”, we explored how digital endpoints are key to the future of clinical trials for biotechs for so many reasons, including improving accuracy, speed, and cost-effectiveness, while aligning with a more patient-centric and data-driven approach.

We're back with a brand new podcast episode: Transforming Clinical Trials: How Digital Endpoints Are Leading the Way. Seuss+ CEO and Co-Founder Sabine Hutchison is joined by two special guests Victoria Bangieva, PhD from the Digital Medicine Society (DiMe) and our very own Director of Digital Innovation, Lauren Alani. This episode dives deep into the challenges and opportunities in developing frameworks and resources to support continued investment in digital strategies that align with business goals and industry standards. It's a must-listen for anyone interested in the future of clinical trials. Available now on all your favorite podcasting platforms. https://lnkd.in/g772_AQK #DigitalHealth #ClinicalTrials #Innovation #Podcast #LifeScience #SeussPlus #DigitalMedicine

Welcome to the August Seuss+ Newsletter We’re nearing the end of summer vacation time here in Europe – always a good moment to take a moment to refuel and prepare for a new season. In this edition, we share some inspiration and information: updates on industry financing and top performers, opportunities to learn from Seuss+, and content to help you make decisions about vendor relationships going forward. Ready to get started? #monthlyinsights #lifesciencenews

We’re thrilled to welcome Abigail Healy to our ever-growing team as our new Business Developer. With over a decade of experience in the life sciences sector, Abbie is a dynamic force focused on growth and innovation. Curious to know more about Abbie? We sat down with her for a quick Q&A to dive deeper into her journey, inspirations, and what she hopes to achieve at Seuss+ https://hubs.ly/Q02N7BB70 #WelcomeAbigail #SeussPlus #LifeSciences #Innovation #TeamGrowth